Pramodini Medicare Files IPO Papers to Raise Capital for Capital Expenditures

Pramodini Medicare Files Draft Red Herring Prospectus for IPO

Andhra Pradesh-based diagnostic service provider Pramodini Medicare has taken a significant step towards raising funds for capital expenditure by filing a Draft Red Herring Prospectus with the NSE Emerge. The company plans to mobilize funds through an initial public offering (IPO), which will involve the issuance of 58.51 lakh shares. This will comprise a fresh issuance of 53.5 lakh shares and an offer-for-sale of 5 lakh shares by promoters.

Pramodini Medicare operates a business that provides diagnostic services such as radiology, clinical laboratory, and nuclear medicine services to public hospitals, private hospitals, certain PSU (public sector undertaking), and medical colleges. The company's business model operates across four key models - public private partnership (with government hospitals and government teaching hospitals), private private partnership (with private sector hospitals), strategic partnership with PSUs, and private centres (standalone centres). With 15 diagnostic centres in 6 states, Pramodini Medicare aims to utilize the Rs 45.1 crore proceeds from the fresh offer for purchasing medical equipment for existing and proposed diagnostic centres, and the remaining amount for general corporate purposes and unidentified inorganic acquisition.

In a competitive market that includes listed peers like Invicta Diagnostic, Krsnaa Diagnostics, and Star Imaging & Path Labs, Pramodini Medicare has demonstrated strong financial performance. For the nine months period ended December 2025, the company recorded a profit of Rs 12.5 crore and revenue of Rs 44.4 crore. Notably, profit in the year ended March 2025 grew by 74.3 percent to Rs 10.04 crore from Rs 5.76 crore in the previous year, while revenue during the same period increased by 8.5 percent to Rs 38.2 crore from Rs 35.2 crore.

Read also: Adisoft Technologies' IPO Generates Strong Demand on Second Day

The Pramodini Medicare IPO has appointed Smart Horizon Capital Advisors as the merchant banker. With this development, the company is poised to take its next step towards expansion and growth.

Note: Growth rates for Invicta Diagnostic, Krsnaa Diagnostics, and Star Imaging & Path Labs are not available.